Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden · Delayed Price · Currency is SEK 183.90
-2.30 (-1.24%)
Dec 23, 2025, 2:19 PM CET
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 5.87 billion as of December 23, 2025. Its market cap has decreased by -60.13% in one year.
Market Cap
5.87B
Enterprise Value
5.71B
Revenue
813.59M
Ranking
n/a
PE Ratio
196.15
Stock Price
183.90
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 5.87B, an increase of 1,477.97%. That is a compound annual growth rate of 23.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 5.87B | -61.92% |
| Dec 30, 2024 | 15.40B | 48.41% |
| Dec 29, 2023 | 10.38B | 90.12% |
| Dec 30, 2022 | 5.46B | -33.55% |
| Dec 30, 2021 | 8.22B | -8.90% |
| Dec 30, 2020 | 9.02B | 99.42% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 114.15B |
| Getinge AB | 58.04B |
| Sectra AB | 48.74B |
| Camurus AB | 36.32B |
| Medicover AB | 33.22B |
| Asker Healthcare Group AB | 32.47B |
| BioArctic AB | 28.19B |
| Elekta AB | 21.43B |